海外の治験の状況「1」での検索結果
259件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- 207966 or "ATLAS-2M" is a study to compare two drugs called Cabotegravir and Rilpivirine when given as long acting injections either every 8 weeks or every 4 weeks in adults with HIV.
- Human Immunodeficiency Virus type 1 (HIV-1) MedDRA version: 20.1 Level: LLT Classification code 10003582 Term: Asymptomatic human immunodeficiency virus type I infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Argentina, Australia, Canada, France, Germany, Italy, Korea, Democratic People's Republic of, Mexico, Russian Federation, South Africa, Spain, Sweden, United States
- 2017-10-18
Authorised
- 207966 or "ATLAS-2M" is a study to compare two drugs called Cabotegravir and Rilpivirine when given as long acting injections either every 8 weeks or every 4 weeks in adults with HIV.
- Human Immunodeficiency Virus type 1 (HIV-1) MedDRA version: 20.0 Level: LLT Classification code 10003582 Term: Asymptomatic human immunodeficiency virus type I infection System Organ Class: 100000020183 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Argentina, Australia, Canada, France, Germany, Italy, Korea, Democratic People's Republic of, Mexico, Russian Federation, South Africa, Spain, Sweden, United States
- 2017-09-18
Authorised
- Clinical trial using GSK525762 in combination with fulvestrant in subjects with breast cancer.
- ER-positive Breast Cancer MedDRA version: 20.1 Level: LLT Classification code 10070575 Term: Estrogen receptor positive breast cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, France, Korea, Republic of, Spain, United Kingdom, United States
- 2017-01-03
Authorised
- A Phase 3 study to investigate Efficacy and Safety of BGB-A317 in patients with Non-Small Cell Lung Cancer
- Previously treated Non-Small Cell Lung Cancer in the second or third line setting. MedDRA version: 20.0 Level: PT Classification code 10061873 Term: Non-small cell lung cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Brazil, Bulgaria, China, Lithuania, Mexico, New Zealand, Poland, Russian Federation, Slovakia, Turkey
- 2018-05-28
Authorised
- Phase 3 Study of Pembrolizumab/Epacadostat/Chemotherapy in Metastatic NSCLC
- First-line treatment of metastatic NSCLC MedDRA version: 20.0 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Spain, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2018-03-12
Authorised
- 201584 or “FLAIR” is a study to compare two drugs (called Cabotegravir and Rilpivirine, as oral tablets followed by long-acting injections) to a single tablet regimen containing 3 HIV drugs (called Triumeq)
- Human Immunodeficiency Virus type 1 (HIV-1) MedDRA version: 19.0 Level: LLT Classification code 10003582 Term: Asymptomatic human immunodeficiency virus type I infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Canada, France, Germany, Italy, Japan, Netherlands, Russian Federation, South Africa, Spain, United Kingdom, United States
- 2016-08-05
Authorised
- A Phase III study to compare two drugs (called Cabotegravir and Rilpivirine, as oral tablets followed by long-acting injections) to current HIV regimens containing three drugs
- Human Immunodeficiency Virus type 1 (HIV-1) MedDRA version: 19.0 Level: LLT Classification code 10003582 Term: Asymptomatic human immunodeficiency virus type I infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Argentina, Australia, Canada, France, Germany, Italy, Korea, Democratic People's Republic of, Mexico, Russian Federation, South Africa, Spain, Sweden, United States
- 2016-08-05
Authorised
- Phase 1-2 Study in Patients with Advanced Gastrointestinal Malignancies Focusing on Hepatocelluar Carcinoma, to determine the treatment effect of ADI-PEG 20 given in combination with chemotherapy drugs folinic acid (leucovorin), fluorouracil and oxaliplatin (FOLFOX).
- Advanced hepatocellular carcinoma (HCC)in the third line or later setting br>MedDRA version: 20.0 Level: LLT Classification code 10049010 Term: Carcinoma hepatocellular System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- China, France, Germany, Italy, Taiwan, United Kingdom, United States
- 2017-12-11
Authorised
- Phase 2 Study of Pembrolizumab/Epacadostat/Chemotherapy in Metastatic NSCLC
- First-line treatment of metastatic NSCLC MedDRA version: 20.0 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
- 2017-11-22
Authorised
- A study of the Combination of Ibrutinib plus Venetoclax versus Chlorambucil plus Obinutuzumab for the First-line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) MedDRA version: 20.1 Level: LLT Classification code 10008976 Term: Chronic lymphocytic leukemia System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Canada, Czech Republic, Denmark, France, Israel, Netherlands, Poland, Russian Federation, Spain, Sweden, Turkey, United Kingdom
- 2018-02-06
